10 papers analyzed
These studies suggest that brexanolone is an effective and safe treatment for moderate to severe postpartum depression, showing significant reductions in depression scores and rapid onset of action, though concerns about high costs, adverse effects, and access limitations exist.
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Brexanolone: First Global Approval
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations
Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression
Brexanolone for postpartum depression
Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
Brexanolone: A Novel Drug for the Treatment of Postpartum Depression
Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
How much Cranberry should I take daily?
why is language unique to humans
What is the impact of e-waste on the environment?
What are the relationships between observation, theory, and experimentation?
What is the role of citizen science in advancing environmental research and conservation?
What are the treatment options for varicose veins?